Skip to content
Menu

Celldex ends eczema drug development after mid-stage trial failure

This page contains a summary, not the full article. Continue to reuters.com to read the original report.

Celldex Therapeutics said on Thursday it would stop developing its experimental drug ​for eczema after the treatment failed to ‌meet the main and key secondary goals of a mid-stage study.

Read at reuters.com